Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma
单位：[1]Capital Med Univ, Chaoyang Hosp, Beijing, Peoples R China北京朝阳医院[2]Beijing Sunbio Biotech Co Ltd, Beijing, Peoples R China[3]Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China[4]Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China[5]Peking Union Med Coll, Tianjin, Peoples R China[6]Shanghai Changzheng Hosp, Shanghai, Peoples R China[7]Hebei Med Univ, Hosp 2, Shijiazhuang, Peoples R China[8]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[9]Peking Univ, Hosp 3, Beijing 100871, Peoples R China[10]Sichuan Univ, West China Hosp, Chengdu 610064, Peoples R China四川大学华西医院
第一作者单位：[1]Capital Med Univ, Chaoyang Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Chen Wenming,Wei Peng,Yang Shifang,et al.Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma[J].BLOOD.2014,124(21):doi:10.1182/blood.V124.21.3478.3478.
APA：
Chen, Wenming,Wei, Peng,Yang, Shifang,Zheng, Xiangjun,Qiu, Lugui...&Pang, Hongyan.(2014).Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma.BLOOD,124,(21)
MLA：
Chen, Wenming,et al."Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma".BLOOD 124..21(2014)
医学